ConcenTrace Trace Mineral Tablets
Natural health product licensed in Canada
- Licence holder
- TRACE MINERALS CANADA, ULC
- NPN or DIN-HM
- 80085618
- Status
- Active licence
- Licence date
- 29 May 2018
- Revision date
- 18 August 2023
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Oxyde de magnésium | 12 mg | 36,000 µg |
| Potassium Source : Chlorure de potassium | 13.33 mg | 39,990 µg |
| Eau de mer intérieure dessalée concentrée Source : Concentrated desalinated Inland Sea water Potency : 91.1 mg Magnesium | 624 mg | Not calculated |
| Calcium Source : Carbonate de calcium | 23.33 mg | 69,990 µg |
| Fer Source : Diglycinate de fer (II) | 0.93 mg | 2,790 µg |
| Medicago sativa Source : Sommité | 54.4 mg | Not calculated |
| Laminaria digitata Source : En entier Potency : 0.4 % Iodine | 51 mg | Not calculated |
| Bore Source : Citrate de bore | 0.33 mg | Not calculated |
| Sodium Source : Citrate de sodium | 6.5 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium, Cire de Carnauba, Acide stéarique, Cellulose microcristalline, Glaçure pharmaceutique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Comprimé | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of minerals. Source of electrolytes. Helps to maintain normal muscle function. Helps in the process of normal regulation of cell division and specialisation. Helps to form red blood cells and helps in their proper function. Helps to reduce tiredness and fatigue caused by iron deficiency anemia. Helps to maintain normal electrolyte balance. Helps to maintain the body's ability to metabolize nutrients. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps maintain healthy calcium metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085618
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging